GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tasly Pharmaceutical Group Co Ltd (SHSE:600535) » Definitions » 14-Day RSI

Tasly Pharmaceutical Group Co (SHSE:600535) 14-Day RSI : 51.88 (As of Dec. 14, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Tasly Pharmaceutical Group Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-14), Tasly Pharmaceutical Group Co's 14-Day RSI is 51.88.

The industry rank for Tasly Pharmaceutical Group Co's 14-Day RSI or its related term are showing as below:

SHSE:600535's 14-Day RSI is ranked worse than
68.86% of 1095 companies
in the Drug Manufacturers industry
Industry Median: 49.56 vs SHSE:600535: 51.88

Competitive Comparison of Tasly Pharmaceutical Group Co's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Tasly Pharmaceutical Group Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tasly Pharmaceutical Group Co's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tasly Pharmaceutical Group Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Tasly Pharmaceutical Group Co's 14-Day RSI falls into.



Tasly Pharmaceutical Group Co  (SHSE:600535) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tasly Pharmaceutical Group Co  (SHSE:600535) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Tasly Pharmaceutical Group Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Tasly Pharmaceutical Group Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Tasly Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
2 Pujihe Road East, Beichen District, Tasly TCM Garden, Tianjin, CHN, 300410
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.
Executives
Wu Nai Feng Director

Tasly Pharmaceutical Group Co Headlines

No Headlines